Acquired Bleeding Disorders

• Published in: Emergency medicine clinics of North America Vol. 32; no. 3; pp. 691 - 713
• Main Authors: Hurwitz, Alisheba, MD, Massone, Richard, MD, Lopez, Bernard L., MD, MS
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-08-2014
• Subjects: Anticoagulant; Bleeding; Blood Coagulation Disorders - diagnosis; Blood Coagulation Disorders - drug therapy; Blood Coagulation Disorders - etiology; Blood Coagulation Factors - therapeutic use; Coagulopathy; Emergency; Emergency Service, Hospital; Hemorrhage; Hemostasis; Hemostasis - physiology; Humans; Platelet Aggregation Inhibitors - therapeutic use; Thrombocytopenia; Transfusion; Thrombocytopenia; Transfusion; Hemostasis; Anticoagulant; Emergency; Hemorrhage; Bleeding; Coagulopathy
• ISSN: 0733-8627; 1558-0539
• DOI: 10.1016/j.emc.2014.04.010

Emergency medicine practitioners treat bleeding patients on a regular basis. Disorders of hemostasis are an additional challenge in these patients but can be assessed and managed in a systematic fashion. Of particular importance to the emergency clinician are the iatrogenic causes of abnormal hemostasis. Other acquired causes of abnormal hemostasis include renal disease, immune thrombocytopenia, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, acquired coagulation factor inhibitors, acute traumatic coagulopathy, liver disease, and disseminated intravascular coagulopathy.